|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for GGA3 |
 Gene summary |
| Basic gene Info. | Gene symbol | GGA3 |
| Gene name | golgi-associated, gamma adaptin ear containing, ARF binding protein 3 | |
| Synonyms | - | |
| Cytomap | UCSC genome browser: 17q25.1 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001172703.2, NM_001172704.2,NM_001291641.1,NM_001291642.1,NM_014001.4, NM_138619.3,NR_033345.1, | |
| Description | ADP-ribosylation factor-binding protein GGA3Golgi-localized, gamma ear-containing, ARF-binding protein 3 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 606006 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000125447 | ||
| HPRD : 10443 | ||
| Vega : OTTHUMG00000179483 | ||
| Protein | UniProt: Q9NZ52 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_GGA3 | |
| BioGPS: 23163 | ||
| Pathway | NCI Pathway Interaction Database: GGA3 | |
| KEGG: GGA3 | ||
| REACTOME: GGA3 | ||
| Pathway Commons: GGA3 | ||
| Context | iHOP: GGA3 | |
| ligand binding site mutation search in PubMed: GGA3 | ||
| UCL Cancer Institute: GGA3 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID |
| Top |
| Ligand binding site mutations for GGA3 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | K95 | K95Q | LUAD | 1 | L138 | L138P | STAD | 1 | L656 | L656S | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for GGA3 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | L656 | L656S | -1.3337864 | K95 | K95Q | -1.1437052 | L138 | L138P | -1.1073557 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for GGA3 from PDB |
| Top |
| Differential gene expression and gene-gene network for GGA3 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for GGA3 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for GGA3 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of GGA3 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1jpl | A | K95 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1jpl | C | K95 | III | Peptide ligand (ASP,SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1jpl | D | K95 | III | Peptide ligand (ASP,ASP,HIS,LEU,LEU) | 1juq | A | K95 | III | Peptide ligand (ASP,ASP,HIS,LEU,LEU,PRO,MET) | 1juq | B | K95 | III | Peptide ligand (ASP,ASP,HIS,LEU,LEU) | 1juq | C | K95 | III | Peptide ligand (ARG,ASP,ASP,HIS,LEU,LEU,PRO,MET) | 1juq | D | K95 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1lf8 | D | K95 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1jpl | B | K95 L138 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1lf8 | B | K95 L138 | III | Peptide ligand (SER,ASP,GLU,ASP,LEU,LEU,HIS,ILE) | 1lf8 | C | K95 L138 | III | Peptide ligand (ASP,PHE,GLY,PRO,LEU,VAL,GLY,ALA) | 1p4u | A | L656 |
| Top |
| Conservation information for LBS of GGA3 |
| Multiple alignments for Q9NZ52 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |